Alignment Healthcare, Inc. $ALHC Shares Bought by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. increased its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 101.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 69,497 shares of the company's stock after acquiring an additional 35,000 shares during the quarter. Adage Capital Partners GP L.L.C.'s holdings in Alignment Healthcare were worth $1,294,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after acquiring an additional 1,295,825 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Alignment Healthcare by 5.0% during the first quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company's stock worth $169,035,000 after purchasing an additional 429,071 shares during the period. Wellington Management Group LLP raised its stake in Alignment Healthcare by 0.9% during the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock worth $139,819,000 after purchasing an additional 70,557 shares during the period. 8 Knots Management LLC raised its stake in Alignment Healthcare by 28.9% during the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company's stock worth $87,802,000 after purchasing an additional 1,056,777 shares during the period. Finally, Millennium Management LLC raised its stake in Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock worth $38,122,000 after purchasing an additional 2,896,311 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ALHC shares. Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Stock Down 1.9%

ALHC traded down $0.31 during trading hours on Friday, reaching $16.04. 3,797,490 shares of the stock traded hands, compared to its average volume of 3,708,480. The firm's fifty day simple moving average is $14.40 and its two-hundred day simple moving average is $15.53. The company has a market cap of $3.18 billion, a price-to-earnings ratio of -57.28 and a beta of 1.17. Alignment Healthcare, Inc. has a fifty-two week low of $9.15 and a fifty-two week high of $21.06. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's revenue was up 49.0% on a year-over-year basis. During the same period last year, the business earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 355,018 shares of the firm's stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the completion of the transaction, the chief executive officer directly owned 4,533,568 shares of the company's stock, valued at $74,395,850.88. This trade represents a 7.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Dawn Christine Maroney sold 215,662 shares of the firm's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the transaction, the president directly owned 1,797,237 shares of the company's stock, valued at approximately $29,492,659.17. This represents a 10.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,262,077 shares of company stock worth $19,805,859 over the last 90 days. Company insiders own 7.00% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.